Skip to content

Influence Continuous Veno-venous Hemodialysis the Autoregulation

Influence of Continuous Veno-venous Hemodialysis on Cerebrovascular Autoregulation in Patients With Acute Renal Failure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01376531
Acronym
dARICUCVVH
Enrollment
20
Registered
2011-06-20
Start date
2011-01-31
Completion date
2011-06-30
Last updated
2013-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Renal Failure

Keywords

acute renal failure, cerebrovascular autoregulation, transcranial Doppler, continuous veno-venous hemodialysis

Brief summary

The aim of the study is to characterize the influence of continuous veno-venous hemodialysis on the cerebrovascular autoregulation.

Detailed description

Patients at the intensive care unit who suffered acute renal failure with the need of continuous veno-venous hemodialysis will be investigated with continuous veno-venous hemodialysis and in a time window without continuous veno-venous hemodialysis to investigate the influence of continuous veno-venous hemodialysis on the cerebrovascular autoregulation.

Interventions

continuous veno-venous hemodialysis

Sponsors

Johannes Gutenberg University Mainz
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute renal failure * need for continuous veno-venous hemodialysis * age \>18 Years

Exclusion criteria

* Sepsis * Preexisting cerebral illness * traumatic brain injury * Meningitis or encephalitis * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline cerebrovascular autoregulation to cerebrovascular autoregulation during continuous veno-venous hemodialysis1 YearIs there an influence of continuous veno-venous hemodialysis at the cerebrovascular autoregulation, which would be a side effect with limiting use in patients with brain injury or the need of intensive monitoring of cerebral perfusion pressure in this patients.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026